Publications

publication

Publishing date: 24/02/2024

[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617

publication

Publishing date: 01/07/2025

161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer

publication

Publishing date: 02/06/2025

161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas

publication

Publishing date: 08/04/2025

First-in-human administration of [161Tb]Tb-SibuDAB and comparative dosimetry with standard [177Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study

publication

Publishing date: 08/07/2024

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum

publication

Publishing date: 08/01/2025

161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer

publication

Publishing date: 01/10/2024

The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for 161Tb Compared with 177Lu with a Higher Dose Response for [161Tb]Tb-DOTA-LM3 Than for [161Tb]Tb-DOTATATE

publication

Publishing date: 17/02/2024

Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside

publication

Publishing date: 30/10/2023

The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods

publication

Publishing date: 10/10/2023

Membrane and Nuclear Absorbed Doses from 177Lu and 161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting-A Monte Carlo Study

publication

Publishing date: 01/04/2023

Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE-A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours

publication

Publishing date: 12/04/2021

Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging

publication

Publishing date: 01/05/2023

New Horizons in Radioligand Therapy: 161Tb-PSMA-617 in Advanced mCRPC

Minervum 7070
4817 ZK Breda
The Netherlands

T: +31 (0)76-8200970
E: support@terthera.com
I: www.terthera.com

Contact us